Universal healthcare coverage is a pivotal element of sustainable development, serving as a facilitator towards achieving health equity and advancing global well-being. As healthcare systems strive to ensure accessibility and affordability of services, the integration of innovative medical products becomes crucial. However, navigating the complexities of financing these systems and maintaining the momentum of medical innovation poses significant challenges across all regions, from economically disadvantaged to wealthier nations. These challenges are often amplified by the need to balance innovation with cost-effectiveness, accessibility, and equitable distribution of healthcare resources.
This Collection, "Healthcare Coverage and Access to Innovative Medical Products: From Theory to Practice," seeks to address these pressing concerns by focusing on research that bridges theoretical frameworks with empirical insights. We aim to delve into how different healthcare systems tackle the inclusion of innovative treatments, pharmaceuticals, and medical technologies, and the role of policy in facilitating or hindering these processes. Particular emphasis is placed on studies that offer methodological innovations, shedding new light on the dynamics of healthcare coverage and access.
By exploring these dimensions, this Collection aspires to contribute to the discourse on sustainable healthcare development, enabling stakeholders to devise strategies that not only enhance healthcare delivery but also foster innovation. We invite contributions that explore these themes, especially those that provide comprehensive analyses or novel methodologies that can inform policymaking and healthcare practices in diverse settings.
Keywords: healthcare coverage, healthcare systems, innovative, medicine, medical products, devices, healthcare financing, evidence, access, cancer, rare disease